In certain situations, the FDA can issue an Emergency Use Authorization (EUA) to facilitate the availability of medical countermeasures, including vaccines, during public health emergencies. An EUA allows the use of unapproved medical products or unapproved uses of approved medical products when there are no adequate, approved, and available alternatives. This was notably used for the rapid deployment of COVID-19 vaccines.
